Found: 6
Select item for more details and to access through your institution.
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.
- Published in:
- Clinical Breast Cancer, 2024, v. 24, n. 2, p. 103, doi. 10.1016/j.clbc.2023.10.009
- By:
- Publication type:
- Article
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 205, n. 2, p. 287, doi. 10.1007/s10549-023-07235-0
- By:
- Publication type:
- Article
The prognostic impact of BMI in patients with HR+/HER2− advanced breast cancer: a study of the SONABRE registry.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 203, n. 2, p. 339, doi. 10.1007/s10549-023-07108-6
- By:
- Publication type:
- Article
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 198, n. 2, p. 239, doi. 10.1007/s10549-022-06832-9
- By:
- Publication type:
- Article
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
- Published in:
- Breast Cancer Research & Treatment, 2022, v. 192, n. 2, p. 331, doi. 10.1007/s10549-021-06472-5
- By:
- Publication type:
- Article
The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2− advanced breast cancer patients: A study of the Dutch SONABRE Registry.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 1, p. 124, doi. 10.1002/ijc.33785
- By:
- Publication type:
- Article